| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Salinomycin is a polyether ionophore antibiotic that is produced by the bacterium Streptomyces albus. It was first isolated in 1979 and has been found to have a range of biological activities, including antibacterial, antifungal, and anticancer properties. It has been shown to induce apoptosis (programmed cell death) in a range of cancer cell lines, including breast, lung, and colon cancer cells. Salinomycin has also been found to inhibit the growth of cancer stem cells. Salinomycin, a widely used antibiotic in poultry farming Actions: -Strong activity against cancer stem cells -Disrupts mitochondrial ion gradients → ROS -Non-thiol, non-NRF2 dominant Key pathways -Mitochondrial K⁺ dysregulation -ROS-mediated apoptosis -Wnt/β-catenin inhibition Chemo relevance -Generally compatible or synergistic -Not a redox buffer
|
| Source: |
| Type: |
| ABC (ATP-binding cassette) transporters are a family of proteins that play a crucial role in the transport of various molecules across cell membranes. ABC transporters have been implicated in the development of multidrug resistance, which is a major obstacle in cancer treatment. Overexpression of certain ABC transporters, such as P-glycoprotein (P-gp), has been observed in various types of cancer, including breast, lung, and colon cancer. Examples of ABC transporters implicated in cancer include: - P-glycoprotein (P-gp, ABCB1) - Multidrug resistance-associated protein 1 (MRP1, ABCC1) - Breast cancer resistance protein (BCRP, ABCG2) Prognostic Implications -Drug Resistance: High expression of ABC transporters is often linked to resistance against chemotherapy, leading to treatment failure and poor patient outcomes. -Survival Rates: Patients with tumors expressing high levels of certain ABC transporters may have lower overall survival rates. Target for Therapy: Inhibitors of ABC transporters are being explored as potential adjuncts to improve the efficacy of chemotherapy. |
| 4906- | Sal, | A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022) |
| - | Review, | BC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:203 Target#:621 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid